Schedule 13D ownership disclosure
Sun BioPharma, Inc.
Security class unavailable · CUSIP: 86664M107
Event date: 2018-12-21
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 555,538
- Percent of class
- 11.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001437749-19-001224
- Form type
- SC 13D
- Filer
- GILBERTSON RYAN RANDALL
- CIK
- CIK 1394821
- Filed
- Jan 24, 2019
- Reporting period
- Dec 21, 2018
- Description
- Schedule 13D beneficial ownership